Patents by Inventor Victoria A. O'Neill

Victoria A. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 11844796
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: December 19, 2023
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20230293445
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: May 25, 2023
    Publication date: September 21, 2023
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 11730702
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: August 22, 2023
    Assignee: Clexio Biosciences, Ltd.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 11534409
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: December 27, 2022
    Assignee: Clexio Biosciences Ltd.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20220110879
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20220071990
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Dinesh K. HASWANI, Derek V. MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 11207318
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: December 28, 2021
    Assignee: Clexio Biosciences Ltd.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20210085617
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: December 3, 2020
    Publication date: March 25, 2021
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 10888528
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: January 12, 2021
    Assignee: Clexio Biosciences Ltd.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20200179405
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20200155544
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Inventors: Dinesh K. HASWANI, Derek V. MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 10568881
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: February 25, 2020
    Assignee: Clexio Biosciences Ltd.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20190133961
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 9, 2019
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 10201505
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: February 12, 2019
    Assignee: CIMA LABS INC.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20180193358
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 12, 2018
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20180185354
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Inventors: Dinesh K. HASWANI, Derek V. MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 9827204
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: November 28, 2017
    Assignee: Cima Labs Inc.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 9757371
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: September 12, 2017
    Assignee: Cima Labs Inc.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20170239271
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: October 3, 2016
    Publication date: August 24, 2017
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • Immediate release abuse-deterrent granulated dosage forms
    Patent number: 9707224
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: July 18, 2017
    Assignee: Cima Labs Inc.
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda